Fredrickson classification type IV Hyperlipidemia
Also known as: Fredrickson Type IV lipidaemia / Fredrickson Type IV lipidemia / Frederickson Type IV Hypertriglyceridemia / Pure hyperglyceridemia / Type IV lipidemia / Type IV lipidaemia / Endogenous hyperlipidemia (disorder) / Fredrickson type IV hyperlipoproteinemia (disorder) / Familial hypertriglyceridaemia / Familial hypertriglyceridemia / Familial hypertriglyceridemia (disorder) / Pure hyperglyceridemia (disorder) / Type IV hyperlipidaemia / Type IV hyperlipidemia / Pure hyperglyceridaemia / Type IV hyperlipoproteinaemia / Hyperlipoproteinemia Type IV / Type IV hyperlipoproteinemia
Drug | Drug Name | Drug Description |
---|---|---|
DB09055 | Acipimox | A niacin derivative used in Fredrickson type IIb and type IV hyperlipoproteinemia. |
DB01076 | Atorvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
DB01393 | Bezafibrate | A lipid-lowering fibrate used in the management of primary and secondary hyperlipidaemia, when there is a lack of clinical improvement following lifestyle modifications or correction of the underlying disorder. |
DB03756 | Doconexent | An omega 3 fatty acid used in a variety of nutritional supplements to support central nervous system and cardiovascular health. |
DB01241 | Gemfibrozil | A lipid regulator that is used in the reduction of serum triglyceride levels in high-risk patients with hyperlipidemia. |
Drug | Drug Name | Phase | Status | Count |
---|